Clinical Trial Update: ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of ONC201 with a methionine-restricted diet in metastatic triple negative breast cancer was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• ONC201 (ONC201)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-03-10